pharmacy claims data improve physician quality of care

1
PharmacoEconomics & Outcomes News 404 - 22 Mar 2003 Pharmacy claims data improve physician quality of care The provision of pharmacy claims data is a useful tool to help primary-care physicians detect patients’ nonadherence to therapy and provide improved quality of care, according to researchers from the US. Their prospective, blinded study examined 231 patient visits involving 32 physicians in a US health maintenance organisation, where physicians received a 6-month comprehensive medication-refill history for their patients on the day of consultation (n = 106) or conducted care as usual (controls). Physicians detected significantly more nonadherence to drug therapy among intervention, compared with control, patients (30.5% vs 0%); however, abstracter-detected nonadherence was similar in both groups. The number of drug additions, dosage changes, drug discontinuations and substitutions for formulary medication was also significantly higher in the intervention than in the control group. There were no between-group differences in median drug costs before or after the intervention. Bieszk N, et al. Detection of medication nonadherence through review of pharmacy claims data. American Journal of Health-System Pharmacy 60: 360-366, 15 Feb 2003 800925448 1 PharmacoEconomics & Outcomes News 22 Mar 2003 No. 404 1173-5503/10/0404-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved

Post on 23-Dec-2016

214 views

Category:

Documents


2 download

TRANSCRIPT

PharmacoEconomics & Outcomes News 404 - 22 Mar 2003

Pharmacy claims data improvephysician quality of care

The provision of pharmacy claims data is a useful toolto help primary-care physicians detect patients’nonadherence to therapy and provide improved qualityof care, according to researchers from the US.

Their prospective, blinded study examined 231patient visits involving 32 physicians in a US healthmaintenance organisation, where physicians received a6-month comprehensive medication-refill history fortheir patients on the day of consultation (n = 106) orconducted care as usual (controls). Physicians detectedsignificantly more nonadherence to drug therapy amongintervention, compared with control, patients (30.5% vs0%); however, abstracter-detected nonadherence wassimilar in both groups. The number of drug additions,dosage changes, drug discontinuations andsubstitutions for formulary medication was alsosignificantly higher in the intervention than in thecontrol group. There were no between-groupdifferences in median drug costs before or after theintervention.Bieszk N, et al. Detection of medication nonadherence through review ofpharmacy claims data. American Journal of Health-System Pharmacy 60: 360-366,15 Feb 2003 800925448

1

PharmacoEconomics & Outcomes News 22 Mar 2003 No. 4041173-5503/10/0404-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved